Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Siong Toh

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Frontiers in Cardiovascular Medicine|August 6, 2024
Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysisI-Ning Yang, Chi-Ya Huang, Chun-Ting Yang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 9, 2025
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysisYu-Min Lin, Jheng-Yan Wu, Mei-Chuan Lee, et al.
Journal of Atherosclerosis and Thrombosis|December 13, 2023
Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular InterventionsWei-Ting Chang, Po-Sen Huang, Li-Wei Su, et al.
Cardiovascular Diabetology|October 10, 2021
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific regionChia-Te Liao, Chun-Ting Yang, Han Siong Toh, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 3, 2016
Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacinHung-Jen Tang, Chih-Cheng Lai, Chi-Chung Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 5, 2016
In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificusHung-Jen Tang, Chi-Chung Chen, Chih-Cheng Lai, et al.
Medicine|January 3, 2023
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trialsMei-Chuan Lee, Yi-Ming Hua, Chun-Ting Yang, et al.
Annals of Intensive Care|December 13, 2022
Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysisYu-Min Lin, Mei-Chuan Lee, Han Siong Toh, et al.
Frontiers in Cardiovascular Medicine|November 15, 2021
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific RegionChia-Te Liao, Chun-Ting Yang, Fang-Hsiu Kuo, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 20, 2019
Taiwan guideline on oral pre-exposure prophylaxis for HIV prevention - 2018 updateIsaac Yen-Hao Chu, Stephane Wen-Wei Ku, Chia-Wen Li, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Frontiers in Cardiovascular Medicine|August 6, 2024
Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysisI-Ning Yang, Chi-Ya Huang, Chun-Ting Yang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 9, 2025
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in atherosclerotic cardiovascular disease phenotypes: a systematic review and meta-analysisYu-Min Lin, Jheng-Yan Wu, Mei-Chuan Lee, et al.
Journal of Atherosclerosis and Thrombosis|December 13, 2023
Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular InterventionsWei-Ting Chang, Po-Sen Huang, Li-Wei Su, et al.
Cardiovascular Diabetology|October 10, 2021
Cost-effectiveness evaluation of add-on dapagliflozin for heart failure with reduced ejection fraction from perspective of healthcare systems in Asia-Pacific regionChia-Te Liao, Chun-Ting Yang, Han Siong Toh, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|May 3, 2016
Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacinHung-Jen Tang, Chih-Cheng Lai, Chi-Chung Chen, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 5, 2016
In vitro and in vivo antibacterial activity of tigecycline against Vibrio vulnificusHung-Jen Tang, Chi-Chung Chen, Chih-Cheng Lai, et al.
Medicine|January 3, 2023
Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trialsMei-Chuan Lee, Yi-Ming Hua, Chun-Ting Yang, et al.
Annals of Intensive Care|December 13, 2022
Association of sepsis-induced cardiomyopathy and mortality: a systematic review and meta-analysisYu-Min Lin, Mei-Chuan Lee, Han Siong Toh, et al.
Frontiers in Cardiovascular Medicine|November 15, 2021
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific RegionChia-Te Liao, Chun-Ting Yang, Fang-Hsiu Kuo, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|October 20, 2019
Taiwan guideline on oral pre-exposure prophylaxis for HIV prevention - 2018 updateIsaac Yen-Hao Chu, Stephane Wen-Wei Ku, Chia-Wen Li, et al.
Pageof 5